<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">APD</journal-id><journal-title-group><journal-title>Advances in Parkinson's Disease</journal-title></journal-title-group><issn pub-type="epub">2169-9712</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/apd.2018.71002</article-id><article-id pub-id-type="publisher-id">APD-82630</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject><subject> Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Frequency of Low Vitamin D3 Levels in Subjects with Parkinson’s Disease. A Study Conducted at PMCH, a Tertiary Care Hospital, Nawabshah
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Anwar</surname><given-names>Ali Jamali</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ghulam</surname><given-names>Mustafa Jamali</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bhojo</surname><given-names>Mal Tanwani</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Niaz</surname><given-names>Hussain Jamali</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Moti</surname><given-names>Ram Bhatia</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Medicine, Peoples Medical University of Medical and Health Sciences, Nawabshah, Sindh, Pakistan</addr-line></aff><aff id="aff3"><addr-line>Department of Psychiatry, Peoples Medical University of Medical and Health Sciences, Nawabshah, Sindh, Pakistan</addr-line></aff><aff id="aff2"><addr-line>Department of Physiology, Peoples Medical University of Medical and Health Sciences, Nawabshah, Sindh, Pakistan</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>jamalianwarali@gmail.com(AAJ)</email>;<email>dr_mustafa_jamali72@yahoo.com(GMJ)</email>;<email>bhojomal@hotmail.com(BMT)</email>;<email>niazhussain858@yahoo.com(NHJ)</email>;<email>drbhatia_pn@yahoo.com(MRB)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>30</day><month>01</month><year>2018</year></pub-date><volume>07</volume><issue>01</issue><fpage>7</fpage><lpage>18</lpage><history><date date-type="received"><day>24,</day>	<month>January</month>	<year>2018</year></date><date date-type="rev-recd"><day>23,</day>	<month>February</month>	<year>2018</year>	</date><date date-type="accepted"><day>26,</day>	<month>February</month>	<year>2018</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
   
   Background: Lack of serum vitamin D3 is related to PD (Parkinson’s disease). Currently a valid place for vitamin D3 deficiency in Parkinson disease (PD) has been anticipated. The aim of present research was to evaluate insufficiency of D3 (vitamin) in subjects with PD (Parkinson’s disease). Many of physiological functions connected with higher risk of illness are maintained by vitamin D, which also plays significant task in pathogenesis of calcium homeostasis and skeletal ailments. It forecasts hazard of persistent ailments like malignancy, CVS conditions, and T2DM. Continuous insufficiency of this vitamin may lead to PD. 
   Method: This was a cross sectional study. Conducted at People’s Medical College Hospital, Nawabshah during period of Jan. 2014-Dec. 2016, the sample size of 243 subjects clinically diagnosed as PD was enlisted. Inclusion criteria were all male and female subjects aged &gt;50 years, clinically diagnosed Parkinson’s disease enlisted in research. 
   Results: In 151 (62.1%) subjects, vitamin D3 levels were &lt;30 ng/ml while in 92 (37.9%) subjects, vitamin D3 values were normal (30 - 150 ng/ml) (p = 0.000). 
   Conclusion: Considerably low levels of vitamin D3 were seen in Parkinson’s disease. Our information sustains a legitimate part of vitamin D insufficiency in PD. 
  
 
</p></abstract><kwd-group><kwd>Parkinson’s Disease</kwd><kwd> Vitamin D Deficiency</kwd><kwd> Nawabshah</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Vitamin D, a fat-soluble vitamin, has many biological consequences. It increases absorption of calcium, phosphate and magnesium in gut. Vitamin D3 and D2 (Cholecalciferol, Ergocalciferol) are essential compounds in our body [<xref ref-type="bibr" rid="scirp.82630-ref1">1</xref>] . Parkinson’s Disease is widespread neurological ailment of old age with unidentified cause. PD has great financial burden and social status of people universally. Uneven prevalence and incidence rates may be affected by ecological or hereditary components, approaches for case determination, diagnostic criterion, or age disseminations of investigation populaces may affect outcomes. Equivalence of existing researches is restricted [<xref ref-type="bibr" rid="scirp.82630-ref2">2</xref>] . Vitamin D3 assumes a critical part in pathogenesis of skeletal ailments and calcium homeostasis [<xref ref-type="bibr" rid="scirp.82630-ref3">3</xref>] . Vitamin D insufficiency likewise predicts expanded danger of other perpetual ailments, malignancy, [<xref ref-type="bibr" rid="scirp.82630-ref4">4</xref>] , cardiovascular sicknesses [<xref ref-type="bibr" rid="scirp.82630-ref5">5</xref>] and DM (type 2) [<xref ref-type="bibr" rid="scirp.82630-ref6">6</xref>] . Constantly deficient vitamin D values promote a constant loss of dopaminergic neurons and propose to assume a major part in the pathogenesis of PD [<xref ref-type="bibr" rid="scirp.82630-ref7">7</xref>] . The epidemiological confirmation of a relationship among vitamin D and PD is, however, constrained to cross-sectional researches [<xref ref-type="bibr" rid="scirp.82630-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.82630-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.82630-ref10">10</xref>] .</p><p>Studies had declared that in America (North), hundreds of populations who suffer from PD are vitamin D deficient. There is connection among PD and D3. These results have a strong correlation in old age peoples and fall risks and intimates additional search into the method essential for this connection [<xref ref-type="bibr" rid="scirp.82630-ref11">11</xref>] . Subjects with PD have decreased vitamin D concentrations in relation to controls. PD is a noteworthy reason for incapacity in older people. Biological credibility and epidemiological information show that vitamin D inadequacy may add to PD progression [<xref ref-type="bibr" rid="scirp.82630-ref7">7</xref>] . The recent research explored whether D3 level predicts Parkinson disease occurrence in populace of Pakistan where solar exposure is high from different zones of world. Vitamin D inadequacy had turned into universal issue in the older, kids and grown-ups [<xref ref-type="bibr" rid="scirp.82630-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.82630-ref13">13</xref>] . Lack of vitamin D3 can occur from decreased solar contact [<xref ref-type="bibr" rid="scirp.82630-ref14">14</xref>] . Altered bone mineralization and bony injury are associated with insufficiency leading to softening bony ailments (osteomalacia and rickets) [<xref ref-type="bibr" rid="scirp.82630-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.82630-ref16">16</xref>] . This study will help in future to manage PD patients properly by reducing risk, treating and avoiding complications by giving additional supplements of vitamin D as a primary step by adding the basic element to diet and as drug. <sup> </sup></p></sec><sec id="s2"><title>2. Methods</title><sec id="s2_1"><title>2.1. Subjects and Setting</title><p>A sum of 243 diagnosed PD subjects from local community enrolled during 2014 to 2016 attending Department of Medicine, People’s Medical University Hospital Nawabshah, Sindh, Pakistan. Sample size calculated by OpenEpi version 3, with population size 1.6 million, hypothesized percent frequency of outcome factor in PD 66/100,000, with confidence level 90% and margin of error 10%. Subjects with other neurodegenerative, thyroid ailments, and new change in lifestyle or nutritional status excluded. A questionnaire based interview and complete clinical examination performed in subjects. All aspects of research updated to subjects and signed consent obtained. Educational situation, routine daylight contact, cigarettes, alcohol, head injury, pesticide exposure and medical history taken by direct questions. This study conducted after authorization of Peoples Medical University Hospital ethical committee.</p></sec><sec id="s2_2"><title>2.2. Diagnoses of PD and Vitamin D3 Deficiency</title><p>Parkinson’s disease was diagnosed through UK PD Society Brain Bank clinical diagnostic criteria, [<xref ref-type="bibr" rid="scirp.82630-ref17">17</xref>] clinical history and relevant signs on examination of patients. Vitamin D3 deficiency diagnosed through laboratory analysis of blood samples of PD sufferers. Serum 25(OH)D concentrations &gt; 30 ng/ml normal, &gt;20 and &lt;30 ng/ml insufficiency and deficiency &lt; 20 ng/ml [<xref ref-type="bibr" rid="scirp.82630-ref18">18</xref>] .</p><p>A well-versed printed consent dully signed by subjects with diagnosis of PD obtained and gratifying inclusion criterion attending Medical Departments PMC Hospital Nawabshah. The venous blood drawn, sent to laboratory for analysis of serum Vitamin D3 by Mini Vidas Biomerieux Global Company France. Levels &lt; 30 ng/ml were labeled as Hypovitaminosis D. After collection of investigations, serum Vitamin D3 levels in PD subjects were determined and proforma filled accordingly.</p></sec><sec id="s2_3"><title>2.3. Statistical Analysis</title><p>The important outcome of study was assessment of vitamin D levels in subjects of PD. All gathered figures analyzed by Statistical Package for Social Science (SPSS) software, edition 20.0. Frequency &amp; percentages computed for categorical variables like gender, and Vitamin D levels. Mean and standard deviation considered for variables (quantitative) as age and vitamin D3 levels. Significance of serum Vitamin D was seen with age, gender, duration of PD to see the impact of these on outcomes. P value &lt; 0.05 was considered statistically significant. Variables (Clinical) communicated as mean &#177; standard deviation (SD) or percentage as suitable. Chi-square test utilized to review distinctions in ratios. Affiliation among serum vitamin D3, PD and its duration were investigated by bivarate correlation analysis by changing for the covariates (age, sex, BMI, smoking, liquor utilize, pesticide history, BMI and vitamin D). The relationships between serum 25(OH)D and length of PD were examined by bivarate correlation investigation.</p></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Analyses of Age and Vitamin D</title><p>In recent study there were a total of 243 subjects with PD who were assessed for frequency of vitamin D deficiency. The Mean age of patients was 67.64 with SD &#177; 6.67 years minimum 56 and maximum 85 years respectively. Mean values of vitamin D3 levels were 27.68 with SD &#177; 21.72 ng/ml with minimum 08 ng/ml and maximum values 85.50 ng/ml.</p></sec><sec id="s3_2"><title>3.2. Analyses of Demographic Data</title><p>Most participants were males 170 (70%) and 73 (30%) females, 232 (95.5%) married and 11 (4.5%) were unmarried (p = 0.000). A large number of subjects 162 (66.7%) were from rural and 81(33.3%) from urban community (p = 0.000). By occupation 27 (11.1%) have no any occupation, 73 (30%) house-wives, 100 (41.2%) manual workers and 43 (17.7%) were office workers (p = 0.000). Regarding educational status 64 (26.3%) uneducated, 123 (50.6%) primary to matriculation, 48 (19.8%) intermediate to graduation and only 08 (3.3%) were postgraduates (p = 0.000). A large number of study subjects 213 (87.7%) had no any evidence of PD in family, where as positive family history was observed in 30 (12.3%) subjects (p = 0.000). Evaluating risk factors for PD, history of pesticide contact in 09 (3.7%), smoking 61 (25.1%), alcohol abuse 24 (9.9%) and history of head injury observed in 18 (7.4%) subjects (p = 0.000). BMI normal in 143 (58.8%), over weight in 91 (37.4%) and 09 (3.7%) were obese subjects (p = 0.000). Baseline characteristics of participants as tremors, bradykinesia, speech changes, impaired posture and balance, rigidity and writing changes were observed in 67.1%, 10.7%, 6.2%, 5.8%, 5.3% and 4.9% respectively (p = 0.000). Regarding duration of PD 82 (33.7%) were &lt;01 year, 40 (16.5%) 1 - 2 years, 41 (16.9%) 2 - 5 years, 40 (16.5%) 5 - 10 years and 40 (16.5%) had duration &gt; 10 years (p = 0.000). We identified 151 (62.1%) subjects with vitamin 25(OH)D &lt; 30 ng/ml, remaining 92 (37.9%) have normal vitamin D3 values (30 - 150 ng/ml) (p = 0.000). Insufficiency (10 - 30 ng/ml) found in 148 (60.9%) and deficiency (&lt;10 ng/ml) was seen in 03 (1.2%) subjects (p = 0.000). Rest of chi-square values and df were shown in <xref ref-type="table" rid="table1">Table 1</xref>.</p></sec><sec id="s3_3"><title>3.3. Analyses of Different Correlations</title><p>The correlation of different variables assessed as shown in <xref ref-type="table" rid="table2">Table 2</xref>. We found that vitamin D3 levels (p = 0.000) were strongly correlated with age (p = 0.000), duration of PD (p = 0.000) these were statistically significant, and the analysis of other risk factors of PD were also assessed there was not significant correlation of various risk factors of PD and vitamin D deficiency like head injury (p = 0.017) alcohol (p = 0.358), smoking (p = 0.566), pesticide contact (p = 0.512), family history (p = 0.840) and BMI (p = 0.572) as shown in <xref ref-type="table" rid="table2">Table 2</xref>. The p-value of less than 0.05 was considered statistically significant.</p></sec></sec><sec id="s4"><title>4. Discussion</title><p>Pakistan is underdeveloped country with poor control on population growth and lack of resources. There is lot of hindrances in the health management parameters. Here we had carried out a research on PD and vitamin D3 level. PD is disease of old age. Sun exposure is easily available and prevalent throughout the country except few areas. There is poor concept of sunbath. Our male population remains outdoors most of daytime for earning purpose. Burka/Parda is common hindrances of females for sun exposure. Head injury, pesticide exposure,</p><table-wrap-group id="1"><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Frequency, percentage and chi-square values of study variables</title></caption><table-wrap id="1_1"><table><tbody><thead><tr><th align="center" valign="middle" >Variable</th><th align="center" valign="middle" >Variables details</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent</th><th align="center" valign="middle" >Chi-Square</th><th align="center" valign="middle" >df</th><th align="center" valign="middle" >Asymp. Sig.</th></tr></thead><tr><td align="center" valign="middle" >Variable</td><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >243</td><td align="center" valign="middle" >100.0</td><td align="center" valign="middle"  colspan="3"  >Non-parametric</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Gender</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >170</td><td align="center" valign="middle" >70.0</td><td align="center" valign="middle"  rowspan="2"  >38.720<sup>b</sup></td><td align="center" valign="middle"  rowspan="2"  >1</td><td align="center" valign="middle"  rowspan="2"  >0.000</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >73</td><td align="center" valign="middle" >30.0</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Marital status</td><td align="center" valign="middle" >Married</td><td align="center" valign="middle" >232</td><td align="center" valign="middle" >95.5</td><td align="center" valign="middle"  rowspan="2"  >200.992<sup>b</sup></td><td align="center" valign="middle"  rowspan="2"  >1</td><td align="center" valign="middle"  rowspan="2"  >0.000</td></tr><tr><td align="center" valign="middle" >Unmarried</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >4.5</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Address</td><td align="center" valign="middle" >Rural</td><td align="center" valign="middle" >162</td><td align="center" valign="middle" >66.7</td><td align="center" valign="middle"  rowspan="2"  >27.000<sup>b</sup></td><td align="center" valign="middle"  rowspan="2"  >1</td><td align="center" valign="middle"  rowspan="2"  >0.000</td></tr><tr><td align="center" valign="middle" >Urban</td><td align="center" valign="middle" >81</td><td align="center" valign="middle" >33.3</td></tr><tr><td align="center" valign="middle"  rowspan="4"  >Occupation</td><td align="center" valign="middle" >No Occupation</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >11.1</td><td align="center" valign="middle"  rowspan="4"  >51.765<sup>c</sup></td><td align="center" valign="middle"  rowspan="4"  >3</td><td align="center" valign="middle"  rowspan="4"  >0.000</td></tr><tr><td align="center" valign="middle" >House Wife</td><td align="center" valign="middle" >73</td><td align="center" valign="middle" >30.0</td></tr><tr><td align="center" valign="middle" >Manual Workers</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >41.2</td></tr><tr><td align="center" valign="middle" >Office Workers</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >17.7</td></tr><tr><td align="center" valign="middle"  rowspan="4"  >Education</td><td align="center" valign="middle" >Uneducated</td><td align="center" valign="middle" >64</td><td align="center" valign="middle" >26.3</td><td align="center" valign="middle"  rowspan="4"  >112.440<sup>c</sup></td><td align="center" valign="middle"  rowspan="4"  >3</td><td align="center" valign="middle"  rowspan="4"  >0.000</td></tr><tr><td align="center" valign="middle" >Primary To Matric</td><td align="center" valign="middle" >123</td><td align="center" valign="middle" >50.6</td></tr><tr><td align="center" valign="middle" >Intermediate to Graduate</td><td align="center" valign="middle" >48</td><td align="center" valign="middle" >19.8</td></tr><tr><td align="center" valign="middle" >Post Graduate</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >3.3</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Family Hx</td><td align="center" valign="middle" >Negative Family History PD</td><td align="center" valign="middle" >213</td><td align="center" valign="middle" >87.7</td><td align="center" valign="middle"  rowspan="2"  >137.815<sup>a</sup></td><td align="center" valign="middle"  rowspan="2"  >1</td><td align="center" valign="middle"  rowspan="2"  >0.000</td></tr><tr><td align="center" valign="middle" >Positive Family History PD</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >12.3</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Pesticide contact Hx</td><td align="center" valign="middle" >Pesticide Contact Hx Yes</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >3.7</td><td align="center" valign="middle"  rowspan="2"  >208.333<sup>b</sup></td><td align="center" valign="middle"  rowspan="2"  >1</td><td align="center" valign="middle"  rowspan="2"  >0.000</td></tr><tr><td align="center" valign="middle" >Pesticide Contact Hx No</td><td align="center" valign="middle" >234</td><td align="center" valign="middle" >96.3</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Smoking Hx</td><td align="center" valign="middle" >Smoking Yes</td><td align="center" valign="middle" >61</td><td align="center" valign="middle" >25.1</td><td align="center" valign="middle"  rowspan="2"  >60.251<sup>b</sup></td><td align="center" valign="middle"  rowspan="2"  >1</td><td align="center" valign="middle"  rowspan="2"  >0.000</td></tr><tr><td align="center" valign="middle" >Smoking No</td><td align="center" valign="middle" >182</td><td align="center" valign="middle" >74.9</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Alcohol Hx</td><td align="center" valign="middle" >Alcohol History No</td><td align="center" valign="middle" >219</td><td align="center" valign="middle" >90.1</td><td align="center" valign="middle"  rowspan="2"  >136.585</td><td align="center" valign="middle"  rowspan="2"  >50</td><td align="center" valign="middle"  rowspan="2"  >0.000</td></tr><tr><td align="center" valign="middle" >Alcohol History Yes</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >9.9</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Head injury Hx</td><td align="center" valign="middle" >Head Injury Yes</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >7.4</td><td align="center" valign="middle"  rowspan="2"  >176.333<sup>b</sup></td><td align="center" valign="middle"  rowspan="2"  >1</td><td align="center" valign="middle"  rowspan="2"  >0.000</td></tr><tr><td align="center" valign="middle" >Head Injury No</td><td align="center" valign="middle" >225</td><td align="center" valign="middle" >92.6</td></tr><tr><td align="center" valign="middle"  rowspan="6"  >PD symptoms</td><td align="center" valign="middle" >Tremor</td><td align="center" valign="middle" >163</td><td align="center" valign="middle" >67.1</td><td align="center" valign="middle"  rowspan="6"  >447.840<sup>e</sup></td><td align="center" valign="middle"  rowspan="6"  >5</td><td align="center" valign="middle"  rowspan="6"  >0.000</td></tr><tr><td align="center" valign="middle" >Bradykinesia</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >10.7</td></tr><tr><td align="center" valign="middle" >Speech Changes</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >6.2</td></tr><tr><td align="center" valign="middle" >Impaired Posture &amp; Balance</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >5.8</td></tr><tr><td align="center" valign="middle" >Rigidity</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >5.3</td></tr><tr><td align="center" valign="middle" >Writing Changes &amp; Others</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >4.9</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Vit D</td><td align="center" valign="middle" >Deficiency: 0 - 10 ng/ml</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >1.2</td><td align="center" valign="middle"  rowspan="3"  >209.704<sup>c</sup></td><td align="center" valign="middle"  rowspan="3"  >2</td><td align="center" valign="middle"  rowspan="3"  >0.000</td></tr><tr><td align="center" valign="middle" >Insufficiency: 10 - 30 ng/ml</td><td align="center" valign="middle" >148</td><td align="center" valign="middle" >60.9</td></tr><tr><td align="center" valign="middle" >Sufficiency: 30 - 150 ng/ml</td><td align="center" valign="middle" >92</td><td align="center" valign="middle" >37.9</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Duration of PD (Years)</td><td align="center" valign="middle" >&lt;1</td><td align="center" valign="middle" >82</td><td align="center" valign="middle" >33.7</td><td align="center" valign="middle"  rowspan="2"  >132.025<sup>d</sup></td><td align="center" valign="middle"  rowspan="2"  >4</td><td align="center" valign="middle"  rowspan="2"  >0.000</td></tr><tr><td align="center" valign="middle" >&gt;1 - 2</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >16.5</td></tr></tbody></table></table-wrap><table-wrap id="1_2"><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="3"  ></th><th align="center" valign="middle" >&gt;2 - 5</th><th align="center" valign="middle" >41</th><th align="center" valign="middle" >16.9</th><th align="center" valign="middle"  rowspan="3"  ></th><th align="center" valign="middle"  rowspan="3"  ></th><th align="center" valign="middle"  rowspan="3"  ></th></tr></thead><tr><td align="center" valign="middle" >&gt;5 - 10</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >16.5</td></tr><tr><td align="center" valign="middle" >&gt;10</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >16.5</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Vit D Level</td><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >92</td><td align="center" valign="middle" >37.9</td><td align="center" valign="middle"  rowspan="2"  >14.325<sup>b</sup></td><td align="center" valign="middle"  rowspan="2"  >1</td><td align="center" valign="middle"  rowspan="2"  >0.000</td></tr><tr><td align="center" valign="middle" >Hypovitaminosis D</td><td align="center" valign="middle" >151</td><td align="center" valign="middle" >62.1</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >BMI</td><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >143</td><td align="center" valign="middle" >58.8</td><td align="center" valign="middle"  rowspan="3"  >112.691<sup>a</sup></td><td align="center" valign="middle"  rowspan="3"  >2</td><td align="center" valign="middle"  rowspan="3"  >0.000</td></tr><tr><td align="center" valign="middle" >Over Weight</td><td align="center" valign="middle" >91</td><td align="center" valign="middle" >37.4</td></tr><tr><td align="center" valign="middle" >Obese</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >3.7</td></tr></tbody></table></table-wrap></table-wrap-group><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Correlation of different variables in Parkinson’s disease subjects. Correlations of low levels of Vitamin D levels with other variables of study</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" ></th><th align="center" valign="middle" >Level of vitamin D</th><th align="center" valign="middle" >Duration of PD</th><th align="center" valign="middle" >Age in years</th><th align="center" valign="middle" >Hx of head injury</th><th align="center" valign="middle" >Hx of alcohol intake</th><th align="center" valign="middle" >Cigarette smoking</th><th align="center" valign="middle" >Pesticide contact Hx</th><th align="center" valign="middle" >Family history</th><th align="center" valign="middle" >BMI</th></tr></thead><tr><td align="center" valign="middle"  rowspan="2"  >Level of vitamin D</td><td align="center" valign="middle" >Pearson Correlation</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >−0.649**</td><td align="center" valign="middle" >−0.656**</td><td align="center" valign="middle" >0.153*</td><td align="center" valign="middle" >−0.059</td><td align="center" valign="middle" >−0.037</td><td align="center" valign="middle" >−0.042</td><td align="center" valign="middle" >0.013</td><td align="center" valign="middle" >0.036</td></tr><tr><td align="center" valign="middle" >Sig. (2-tailed)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.000</td><td align="center" valign="middle" >0.000</td><td align="center" valign="middle" >0.017</td><td align="center" valign="middle" >0.358</td><td align="center" valign="middle" >0.566</td><td align="center" valign="middle" >0.512</td><td align="center" valign="middle" >0.840</td><td align="center" valign="middle" >0.572</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Duration of Parkinson’s disease</td><td align="center" valign="middle" >Pearson Correlation</td><td align="center" valign="middle" >−0.649**</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.814**</td><td align="center" valign="middle" >−0.129*</td><td align="center" valign="middle" >0.021</td><td align="center" valign="middle" >−0.077</td><td align="center" valign="middle" >0.130*</td><td align="center" valign="middle" >−0.014</td><td align="center" valign="middle" >0.013</td></tr><tr><td align="center" valign="middle" >Sig. (2-tailed)</td><td align="center" valign="middle" >0.000</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.000</td><td align="center" valign="middle" >0.045</td><td align="center" valign="middle" >0.742</td><td align="center" valign="middle" >0.232</td><td align="center" valign="middle" >0.043</td><td align="center" valign="middle" >0.832</td><td align="center" valign="middle" >0.840</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Age in years</td><td align="center" valign="middle" >Pearson Correlation</td><td align="center" valign="middle" >−0.656**</td><td align="center" valign="middle" >0.814**</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >−0.065</td><td align="center" valign="middle" >−0.030</td><td align="center" valign="middle" >−0.198**</td><td align="center" valign="middle" >0.019</td><td align="center" valign="middle" >−0.098</td><td align="center" valign="middle" >0.004</td></tr><tr><td align="center" valign="middle" >Sig. (2-tailed)</td><td align="center" valign="middle" >0.000</td><td align="center" valign="middle" >0.000</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.314</td><td align="center" valign="middle" >0.646</td><td align="center" valign="middle" >0.002</td><td align="center" valign="middle" >0.771</td><td align="center" valign="middle" >0.128</td><td align="center" valign="middle" >0.953</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >History of head injury</td><td align="center" valign="middle" >Pearson Correlation</td><td align="center" valign="middle" >0.153*</td><td align="center" valign="middle" >−0.129*</td><td align="center" valign="middle" >−0.065</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >−0.064</td><td align="center" valign="middle" >−0.164*</td><td align="center" valign="middle" >−0.055</td><td align="center" valign="middle" >−0.180**</td><td align="center" valign="middle" >0.002</td></tr><tr><td align="center" valign="middle" >Sig. (2-tailed)</td><td align="center" valign="middle" >0.017</td><td align="center" valign="middle" >0.045</td><td align="center" valign="middle" >0.314</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.318</td><td align="center" valign="middle" >0.011</td><td align="center" valign="middle" >0.389</td><td align="center" valign="middle" >0.005</td><td align="center" valign="middle" >0.975</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >History of alcohol intake</td><td align="center" valign="middle" >Pearson Correlation</td><td align="center" valign="middle" >−0.059</td><td align="center" valign="middle" >0.021</td><td align="center" valign="middle" >−0.030</td><td align="center" valign="middle" >−0.064</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.001</td><td align="center" valign="middle" >0.065</td><td align="center" valign="middle" >0.882**</td><td align="center" valign="middle" >0.030</td></tr><tr><td align="center" valign="middle" >Sig. (2-tailed)</td><td align="center" valign="middle" >0.358</td><td align="center" valign="middle" >0.742</td><td align="center" valign="middle" >0.646</td><td align="center" valign="middle" >0.318</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.990</td><td align="center" valign="middle" >0.314</td><td align="center" valign="middle" >0.000</td><td align="center" valign="middle" >0.641</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Cigarette smoking</td><td align="center" valign="middle" >Pearson Correlation</td><td align="center" valign="middle" >−0.037</td><td align="center" valign="middle" >−0.077</td><td align="center" valign="middle" >−0.198**</td><td align="center" valign="middle" >−0.164*</td><td align="center" valign="middle" >0.001</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >−0.114</td><td align="center" valign="middle" >0.044</td><td align="center" valign="middle" >0.006</td></tr><tr><td align="center" valign="middle" >Sig. (2-tailed)</td><td align="center" valign="middle" >0.566</td><td align="center" valign="middle" >0.232</td><td align="center" valign="middle" >0.002</td><td align="center" valign="middle" >0.011</td><td align="center" valign="middle" >0.990</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.077</td><td align="center" valign="middle" >0.493</td><td align="center" valign="middle" >0.925</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Pesticide contact hx</td><td align="center" valign="middle" >Pearson Correlation</td><td align="center" valign="middle" >−0.042</td><td align="center" valign="middle" >0.130*</td><td align="center" valign="middle" >0.019</td><td align="center" valign="middle" >−0.055</td><td align="center" valign="middle" >0.065</td><td align="center" valign="middle" >−0.114</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.074</td><td align="center" valign="middle" >0.001</td></tr><tr><td align="center" valign="middle" >Sig. (2-tailed)</td><td align="center" valign="middle" >0.512</td><td align="center" valign="middle" >0.043</td><td align="center" valign="middle" >0.771</td><td align="center" valign="middle" >0.389</td><td align="center" valign="middle" >0.314</td><td align="center" valign="middle" >0.077</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.253</td><td align="center" valign="middle" >0.982</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Family history</td><td align="center" valign="middle" >Pearson Correlation</td><td align="center" valign="middle" >0.013</td><td align="center" valign="middle" >−0.014</td><td align="center" valign="middle" >−0.098</td><td align="center" valign="middle" >−0.180**</td><td align="center" valign="middle" >0.882**</td><td align="center" valign="middle" >0.044</td><td align="center" valign="middle" >0.074</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.078</td></tr><tr><td align="center" valign="middle" >Sig. (2-tailed)</td><td align="center" valign="middle" >0.840</td><td align="center" valign="middle" >0.832</td><td align="center" valign="middle" >0.128</td><td align="center" valign="middle" >0.005</td><td align="center" valign="middle" >0.000</td><td align="center" valign="middle" >0.493</td><td align="center" valign="middle" >0.253</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.225</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Body Mass Index</td><td align="center" valign="middle" >Pearson Correlation</td><td align="center" valign="middle" >0.036</td><td align="center" valign="middle" >0.013</td><td align="center" valign="middle" >0.004</td><td align="center" valign="middle" >0.002</td><td align="center" valign="middle" >0.030</td><td align="center" valign="middle" >0.006</td><td align="center" valign="middle" >0.001</td><td align="center" valign="middle" >0.078</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >Sig. (2-tailed)</td><td align="center" valign="middle" >0.572</td><td align="center" valign="middle" >0.840</td><td align="center" valign="middle" >0.953</td><td align="center" valign="middle" >0.975</td><td align="center" valign="middle" >0.641</td><td align="center" valign="middle" >0.925</td><td align="center" valign="middle" >0.982</td><td align="center" valign="middle" >0.225</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >N</td><td align="center" valign="middle" >243</td><td align="center" valign="middle" >243</td><td align="center" valign="middle" >243</td><td align="center" valign="middle" >243</td><td align="center" valign="middle" >243</td><td align="center" valign="middle" >243</td><td align="center" valign="middle" >243</td><td align="center" valign="middle" >243</td><td align="center" valign="middle" >243</td></tr></tbody></table></table-wrap><p>*Significant Correlation at 0.05 levels (2-tailed). **Significant Correlation at 0.01 levels (2-tailed).</p><p>smoking are common in comparison to alcoholism and obesity in PD. Due to lack of health education, most of time peoples ignore health issues. Currentlyan established role of vitamin D and PD was identified. We carried out a study in our population to check the presence of low levels of vitamin D3 in PD. There is described role of vitamin D3 lack in PD, vitamin D3 insufficiency leads or progresses to Parkinson’s disease. These issues were focused in different studies in rest of world. Findings of present study are match-able with previous studies as discussed below.</p><p>PD (Parkinson’s disease) is a neurodegenerative disease in a particular zone of the cerebrum called substantia nigra, [<xref ref-type="bibr" rid="scirp.82630-ref19">19</xref>] characterized by inflexible nature, tremors and dyskinesia along with postural insecurity and dementia. Vitamin D had critical effect on neurological illnesses as PD and Dementia. In cerebrum, hippocampus and substantia nigra neurons show high convergences of VDRs in their core and 1-OHase in their cytosol. In present study mean &#177; SD values of age were 67.64 &#177; 6.67 years (age range 56 - 85 years), males 170 (70%) and 73 (30%) were females, our findings are supported in a study by Moghaddasi M et al. in which mean age of the patients were 56.57 &#177; 11.71 years (age range 24 - 79 years); 3 (75.9%) males and 20 (24.1%) were females. Mean age of symptoms onset was 50.71 &#177; 12.10 years (range 20 - 77 years) [<xref ref-type="bibr" rid="scirp.82630-ref20">20</xref>] . With insufficiency of vitamin D, there is hazard of developing PD; this hazard increases to twofold when there is deficiency of vitamin D [<xref ref-type="bibr" rid="scirp.82630-ref21">21</xref>] . Vitamin D levels were low in subjects with PD and AD in comparison to the normal controls, [<xref ref-type="bibr" rid="scirp.82630-ref8">8</xref>] current study also determined insufficiency of vitamin D3 in 61.1% of PD subjects. 25(OH)D3 emphatically connected with intellectual execution, especially with measuring its role in elderly populace [<xref ref-type="bibr" rid="scirp.82630-ref22">22</xref>] . Many of studies (Cross Sectional) had shown the relationship of decreased levels of vitamin D with incident of PD also predicted increased hazard of PD [<xref ref-type="bibr" rid="scirp.82630-ref23">23</xref>] . Vitamin D levels in high-risk group and matched controls (age, sex) did not differ, and it was suggested that there is no deficiency of vitamin D before diagnosis of PD [<xref ref-type="bibr" rid="scirp.82630-ref24">24</xref>] . A majority of researches in established PD had shown lower vitamin D values as compared to fit controls [<xref ref-type="bibr" rid="scirp.82630-ref9">9</xref>] . Serum values of vitamin D decrease as severity of disease increases [<xref ref-type="bibr" rid="scirp.82630-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.82630-ref26">26</xref>] as low levels of vitamin D3 were observed in subjects of PD in this study.</p><p>Nitric Oxide (free radical) can damage to cells, its synthesis is inhibited by vitamin D, and vitamin D3 also causes formation of glutathione (antioxidant) thus plays a neuro-protective role [<xref ref-type="bibr" rid="scirp.82630-ref27">27</xref>] . It is assumed that vitamin D3 is involved in initiating the synthesis of N G F (nerve growth factor), Glial cell line derived factor and NT3 (Neurotrophin) and in this way is considered as Neurotrophic Factor [<xref ref-type="bibr" rid="scirp.82630-ref28">28</xref>] [<xref ref-type="bibr" rid="scirp.82630-ref29">29</xref>] [<xref ref-type="bibr" rid="scirp.82630-ref30">30</xref>] . Peterson et al. in their research found strong relationship of automatic postural responses with serum vitamin D concentrations [<xref ref-type="bibr" rid="scirp.82630-ref31">31</xref>] . Daily vitamin D3 supplements (1200 IU) for one year showed mild progression of disease and worsening of disease observed in those who did not receive increments. [<xref ref-type="bibr" rid="scirp.82630-ref32">32</xref>] As there were presence of more than one symptom of PD, VDD was more common as age of patient increases with more than one symptom. Patients with PD had limited outdoor activities so solar exposure is decreased this may contributes to decreasing levels of vitamin D even with incremental intake [<xref ref-type="bibr" rid="scirp.82630-ref33">33</xref>] .</p><p>Juan Wang et al. showed statistically a significant link among vitamin D values and sun exposure; and no involvement among serum vitamin D and daily oral supplements of vitamin D. There study indicated that low values of this vitamin with reduced sun exposure are associated with increase hazard of PD [<xref ref-type="bibr" rid="scirp.82630-ref34">34</xref>] , above associations of VDD and PD are evident in present study. Yoon JH et al. in their study subjects with early PD, observed the relation among serum vitamin D values and endothelial cell dysfunction [<xref ref-type="bibr" rid="scirp.82630-ref35">35</xref>] . Probable racial variations in passageway for consumed vitamin D may be dilemma crossways to panel suggestions meant for D3 values as in Inuit. Decreased synthesis of this vitamin is balanced in Inuit through transforming lot of vitamin-D towards its chiefly active type [<xref ref-type="bibr" rid="scirp.82630-ref36">36</xref>] . A Toronto research on Canadians (young) from various origins had average vitamin D3 values that were fundamentally elevated from authorized proposals [<xref ref-type="bibr" rid="scirp.82630-ref37">37</xref>] . 22% European, 78% and 77% of Asian (East, South) heritage had vitamin D3 level &lt; 40 nmol/l (15 ng/ml), compared with previous studies. Toronto study in Asians (East) observed decreased vitamin D3 in contrast with White community [<xref ref-type="bibr" rid="scirp.82630-ref38">38</xref>] .</p><p>Rural men around Delhi had average 44 nmol/L of D3, in current study 162 (66.7%) subjects from rural and 81 (33.3%) were urban (p = 0.000), with mean vitamin D3 levels 27.68 &#177; 21.72 ng/ml, these findings are matching with results of study by Rajasree S et al. Normal Indians have decreased vitamin D3, not much unusual than Canadian Asians (South). South Indians with IHD had tremendously increased (&gt;222.5 nmol/l) D3 values [<xref ref-type="bibr" rid="scirp.82630-ref39">39</xref>] . In present study with references to above studies we found that 151 (62.1%) subjects have vitamin D3 &lt;30 ng/ml and remaining 92 (37.9%) have sufficient D3 values (30 - 150 ng/ml) (p value 0.000). Insufficiency (10 - 30 ng/ml) in 148 (60.9%) and deficiency (&lt;10 ng/ml) observed in 03 (1.2%) subjects (p = 0.000). Melanin substance demonstrated opposite association with serum 25(OH)D [<xref ref-type="bibr" rid="scirp.82630-ref37">37</xref>] . Uniformly deficient 25(OH)D values seen in Indians (living in India and China). Noteworthy Hereditary minority of French Canadians didn’t buildup consumed vitamin D3. Vitamin D3 protein binding polymorphisms had a significant part of variety in serum D3 as totaled intake of vitamin D3 [<xref ref-type="bibr" rid="scirp.82630-ref40">40</xref>] [<xref ref-type="bibr" rid="scirp.82630-ref41">41</xref>] . Different methods controlling metabolism with limited extent of vitamin D values in which vascular capacity is streamlined were associated with increased mortality [<xref ref-type="bibr" rid="scirp.82630-ref42">42</xref>] , abnormal functioning and premature aging [<xref ref-type="bibr" rid="scirp.82630-ref43">43</xref>] .</p><p>Worldwide prevalence of vitamin D deficiency/insufficiency accounts for 1 billion people [<xref ref-type="bibr" rid="scirp.82630-ref13">13</xref>] where south Asians are uniformly affected despite abundant sunshine [<xref ref-type="bibr" rid="scirp.82630-ref44">44</xref>] . Pakistan a rising nation of Asia (South) with an area spreading over scope 24˚35' North and longitude 61˚ East to 78˚ East, seriously facing D3 insufficiency in pregnant ladies, neonates, babies, youngsters, teenagers, grown-ups, and elderly individuals regardless of plentiful daylight [<xref ref-type="bibr" rid="scirp.82630-ref45">45</xref>] . 70% fit volunteers in Pakistan, 84% pregnant ladies in India are distressed by VDD. Sri Lanka and Bangladesh are no exception where 26% boys and 8% girls are victims of VDD [<xref ref-type="bibr" rid="scirp.82630-ref46">46</xref>] . A study demonstrated 66.32% of PD and 22.62% of healthy individuals had mild to moderate VDD (cutoff value &lt; 30 ng/ml). Pakistani population in general had VDD and vitamin D supplementation assumed to be added after clinical evaluation of population groups [<xref ref-type="bibr" rid="scirp.82630-ref47">47</xref>] . Mansoor et al. elucidated that 56.9% men and 43.1% normal women had Vitamin D3 &lt; 20 ng/ml [<xref ref-type="bibr" rid="scirp.82630-ref48">48</xref>] . Sheikh et al. observed in 84.3% of tested healthy subjects (38 - 55 years) in Karachi had 25(OH)D levels &lt; 30 ng/ml suggesting extensive VDD prevalence throughout Pakistan declaring Pakistani population a vitamin D deficient [<xref ref-type="bibr" rid="scirp.82630-ref49">49</xref>] .</p><p>Findings of above studies were considerably in contest with present study where we identified 151 (62.1%) subjects have vitamin D3 &lt; 30 ng/ml. A narrowed danger of death in old age observed with high Vitamin D3 levels while others didn’t benefit [<xref ref-type="bibr" rid="scirp.82630-ref50">50</xref>] . Taking supplements are valuable or not still unclear [<xref ref-type="bibr" rid="scirp.82630-ref51">51</xref>] . Increased danger of vitamin D deficiency observed in Blacks comparison to White populace [<xref ref-type="bibr" rid="scirp.82630-ref52">52</xref>] . Further studies needed to find out reasons for these differences and clarify probable part of vitamin D in pathogenesis and clinical path of PD.</p></sec><sec id="s5"><title>5. Conclusion</title><p>Vitamin D deficiency is commonly associated in patients suffering from Parkinson’s disease. As concluded in present research that as the age advances, risk of Parkinson’s disease increases with simultaneous decrease in vitamin D level. As concluded in our study, 62.1% subjects of Parkinson’s disease were vitamin D deficient.</p></sec><sec id="s6"><title>Cite this paper</title><p>Jamali, A.A., Jamali, G.M., Tanwani, B.M., Jamali, N.H. and Bhatia, M.R. (2018) Frequency of Low Vitamin D3 Levels in Subjects with Parkinson’s Disease. A Study Conducted at PMCH, a Tertiary Care Hospital, Nawabshah. Advances in Parkinson’s Disease, 7, 7-18. https://doi.org/10.4236/apd.2018.71002</p></sec></body><back><ref-list><title>References</title><ref id="scirp.82630-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Holick, M.F. (2006) High Prevalence of Vitamin D Inadequacy and Implications for Health. Mayo Clinic Proceedings, 81, 353-373. https://doi.org/10.4065/81.3.353</mixed-citation></ref><ref id="scirp.82630-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Von Campenhausen, S., Bornschein, B., Wick, R., B?tzel, K., et al. (2005) Prevalence and Incidence of Parkinson’s Disease in Europe. European Neuropsychopharmacology, 15, 473-490. https://doi.org/10.1016/j.euroneuro.2005.04.007 </mixed-citation></ref><ref id="scirp.82630-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Grant, W.B. (2006) Epidemiology of Disease Risks in Relation to Vitamin D Insufficiency. Progress in Biophysics and Molecular Biology, 92, 65-79.  
https://doi.org/10.1016/j.pbiomolbio.2006.02.013</mixed-citation></ref><ref id="scirp.82630-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Kilkkinen, A., Knekt, P., Heliovaara, M., et al. (2008) Vitamin D Status and the Risk of Lung Cancer: A Cohort Study in Finland. Cancer Epidemiology, Biomarkers &amp; Prevention, 17, 3274-3278. https://doi.org/10.1158/1055-9965.EPI-08-0199</mixed-citation></ref><ref id="scirp.82630-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Giovannucci, E., Liu, Y., Hollis, B.W. and Rimm, E.B. (2008) 25-Hydroxyvitamin D and Risk of Myocardial Infarction in Men: A Prospective Study. Arch Intern Med, 168, 1174-1180. https://doi.org/10.1001/archinte.168.11.1174</mixed-citation></ref><ref id="scirp.82630-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Knekt, P., Laaksonen, M., Mattila, C., et al. (2008) Serum Vitamin D and Subsequent Occurrence of Type 2 Diabetes. Epidemiology, 19, 666-671.  
https://doi.org/10.1097/EDE.0b013e318176b8ad</mixed-citation></ref><ref id="scirp.82630-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Newmark, H.L. and Newmark, J. (2007) Vitamin D and Parkinson’s Disease—A Hypothesis. Movement Disorders, 22, 461-468. https://doi.org/10.1002/mds.21317</mixed-citation></ref><ref id="scirp.82630-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Evatt, M.L., Delong, M.R., Khazai, N., et al. (2008) Prevalence of Vitamin D Insufficiency in Patients with Parkinson Disease and Alzheimer Disease. Arch Neurol, 65, 1348-1352. https://doi.org/10.1001/archneur.65.10.1348</mixed-citation></ref><ref id="scirp.82630-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Sato, Y., Honda, Y., Iwamoto, J., et al. (2005) Abnormal Bone and Calcium Metabolism in Immobilized Parkinson’s Disease Patients. Movement Disorders, 20, 1598-1603.  
https://doi.org/10.1002/mds.20658</mixed-citation></ref><ref id="scirp.82630-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Sato, Y., Kikuyama, M. and Oizumi, K. (1997) High Prevalence of Vitamin D Deficiency and Reduced Bone Mass in Parkinson’s Disease. Neurology, 49, 1273-1278.  
https://doi.org/10.1212/WNL.49.5.1273</mixed-citation></ref><ref id="scirp.82630-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Hongliu, D., Kaltra, D., Kaitlin, C., et al. (2013) Unrecognized Vitamin D3 Deficiency Is Common in Parkinson Disease: Harvard Biomarker Study. American Academy of Neurology, 81, 1531-1537.</mixed-citation></ref><ref id="scirp.82630-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Eriksen, E.F. and Glerup, H. (2002) Vitamin D Deficiency and Aging: Implications for General Health and Osteoporosis. Biogerontology, 3, 73-77.  
https://doi.org/10.1023/A:1015263514765</mixed-citation></ref><ref id="scirp.82630-ref13"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Holick</surname><given-names> M.F. </given-names></name>,<etal>et al</etal>. (<year>2007</year>)<article-title>Vitamin D deficiency</article-title><source> The New England Journal of Medicine</source><volume> 357</volume>,<fpage> 266</fpage>-<lpage>281</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.82630-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Schoenmakers, I., Goldberg, G.R. and Prentice, A. (2008) Abundant Sunshine and Vitamin D Deficiency. The British Journal of Nutrition, 99, 1171-1173.  
https://doi.org/10.1017/S0007114508898662</mixed-citation></ref><ref id="scirp.82630-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Grant, W.B. and Holick, M.F. (2005) Benefits and Requirements of Vitamin D for Optimal Health: A Review. Alternative Medicine Review, 10, 94-111.</mixed-citation></ref><ref id="scirp.82630-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Brown, J.E., Isaacs, J., et al. (2013) Nutrition through the Life Cycle. Cengage Learning, Boston, MA. http://www.revolvy.com/main/index.php?s</mixed-citation></ref><ref id="scirp.82630-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Hughes, A.J., Daniel, S.E., Kilford, L. and Lees, A.J. (1992) Accuracy of Clinical Diagnosis of Idiopathic Parkinson’s Disease: A Clinico-Pathological Study of 100 Cases. Journal of Neurology, Neurosurgery &amp; Psychiatry, 55, 181-184.  
https://doi.org/10.1136/jnnp.55.3.181</mixed-citation></ref><ref id="scirp.82630-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Shen, L. and Ji, H.F. (2015) Associations between Vitamin D Status, Supplementation, Outdoor Work and Risk of Parkinson’s Disease: A Meta-Analysis Assessment. Nutrients, 7, 4817-4827. https://doi.org/10.3390/nu7064817</mixed-citation></ref><ref id="scirp.82630-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Evatt, M.L., DeLong, M.R., Kumari, M., et al. (2011) High Prevalence of Hypovitaminosis D Status in Patients with Early Parkinson Disease. Archives of Neurology, 68, 314-319. https://doi.org/10.1001/archneurol.2011.30</mixed-citation></ref><ref id="scirp.82630-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Moghaddasi, M., Mamarabadi, M. and Aghaii, M. (2013) Serum 25-Hydroxyvitamin D3 Concentration in Iranian Patients with Parkinson’s Disease. Iranian Journal of Neurology, 12, 56-59.</mixed-citation></ref><ref id="scirp.82630-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Lv, Z., Qi, H., Wang, L., et al. (2014) Vitamin D Status and Parkinson’s Disease: A Systematic Review and Meta-Analysis. Neurological Sciences, 35, 1723-1730.  
https://doi.org/10.1007/s10072-014-1821-6</mixed-citation></ref><ref id="scirp.82630-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Jennifer, S.B., Tammy, M.S., Bess, D.H., et al. (2009) The Journals of Gerontology: Series A, Vitamin D Is Associated with Cognitive Function in Elders Receiving Home Health Services. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 64, 888-895.</mixed-citation></ref><ref id="scirp.82630-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Knekt, P., Kilkkinen, A., Rissanen, H., et al. (2010) Serum Vitamin D and the Risk of Parkinson Disease. Archives of Neurology, 67, 808-811.  
https://doi.org/10.1001/archneurol.2010.120</mixed-citation></ref><ref id="scirp.82630-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Fullard, M.E., Xie, S.X., Marek, K., et al. (2017) Vitamin D in the Parkinson Associated Risk Syndrome (PARS) Study. Movement Disorders, 32, 1636-1640.  
https://doi.org/10.1002/mds.27127</mixed-citation></ref><ref id="scirp.82630-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Rimmelzwaan, L.M., van Schoor, N.M., Lips, P., et al. (2016) Systematic Review of the Relationship between Vitamin D and Parkinson’s Disease. Journal of Parkinson’s Disease, 6, 29-37. https://doi.org/10.3233/JPD-150615</mixed-citation></ref><ref id="scirp.82630-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Ding, H., Dhima, K., Lockhart, K., et al. (2013) Unrecognized Vitamin D3 Deficiency Is Common in Parkinson Disease: Harvard Biomarker Study. Neurology, 81, 1531-1537. https://doi.org/10.1212/WNL.0b013e3182a95818</mixed-citation></ref><ref id="scirp.82630-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Garcion, E., Wion-Barbot, N., Montero-Menei, C.N., et al. (2002) New Clues about Vitamin D Functions in the Nervous System. Trends in Endocrinology Metabolism, 13, 100-105. https://doi.org/10.1016/S1043-2760(01)00547-1</mixed-citation></ref><ref id="scirp.82630-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Naveilhan, P., Neveu, I., Wion, D. and Brachet, P. (1996) 1,25-Dihydroxyvitamin D3, an Inducer of Glial Cell Line-Derived Neurotrophic Factor. Neuroreport, 7, 2171-2175. https://doi.org/10.1097/00001756-199609020-00023</mixed-citation></ref><ref id="scirp.82630-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Musiol, I.M. and Feldman, D. (1997) 1,25-Dihydroxyvitamin D3 Induction of Nerve Growth Factor in L929 Mouse Fibroblasts: Effect of Vitamin D Receptor Regulation and Potency of Vitamin D3 Analogs. Endocrinology, 138, 12-18.  
https://doi.org/10.1210/endo.138.1.4858</mixed-citation></ref><ref id="scirp.82630-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Neveu, I., Naveilhan, P., Baudet, C., Brachet, P. and Metsis, M. (1994) 1, 25-Dihydroxyvitamin D3 Regulates NT-3, NT-4 but Not BDNF mRNA in Astrocytes. Neuroreport, 6, 124-126. https://doi.org/10.1097/00001756-199412300-00032</mixed-citation></ref><ref id="scirp.82630-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Peterson, A.L., Mancini, M. and Horak, F.B. (2013) The Relationship between Balance Control and Vitamin D in Parkinson’s Disease—A Pilot Study. Movement Disorders, 28, 1133-1137. https://doi.org/10.1002/mds.25405</mixed-citation></ref><ref id="scirp.82630-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Suzuki, M., Yoshioka, M., Hashimoto, M., et al. (2013) Randomized, Double-Blind, Placebo-Controlled Trial of Vitamin D Supplementation in Parkinson Disease. The American Journal of Clinical Nutrition, 97, 1004-1013.  
https://doi.org/10.3945/ajcn.112.051664</mixed-citation></ref><ref id="scirp.82630-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Miyake, Y., Tanaka, K., Fukushima, W., et al. (2011) Lack of Association of Dairy Food, Calcium, and Vitamin D Intake with the Risk of Parkinson’s Disease: A Case Control study in Japan. Parkinsonism &amp; Related Disorders, 17, 112-116.  
https://doi.org/10.1016/j.parkreldis.2010.11.018</mixed-citation></ref><ref id="scirp.82630-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Juan, W., Deyu, Y., Yu, Y., et al. (2016) Vitamin D and Sunlight Exposure in Newly-Diagnosed Parkinson’s Disease. Nutrients, 8, 142.  
https://doi.org/10.3390/nu8030142</mixed-citation></ref><ref id="scirp.82630-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Yoon, J.H., Park, D.K., Yong, S.W. and Hong, J.M. (2015) Vitamin D Deficiency and Its Relationship with Endothelial Dysfunction in Patients with Early Parkinson’s Disease. Journal of Neural Transmission (Vienna), 122, 1685-1691.  
https://doi.org/10.1007/s00702-015-1452-y</mixed-citation></ref><ref id="scirp.82630-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Rejnmark, L., J?rgensen, M.E., Pedersen, M.B., et al. (2004) Vitamin D Insufficiency in Greenlanders on a Westernized Fare: Ethnic Differences in Calcitropic Hormones between Greenlanders and Danes. Calcified Tissue International, 74, 255-263.  
https://doi.org/10.1007/s00223-003-0110-9 </mixed-citation></ref><ref id="scirp.82630-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Gozdzik, A., Barta, J.L., Wu, H., et al. (2008) Low Wintertime Vitamin D Levels in a Sample of Healthy Young Adults of Diverse Ancestry Living in the Toronto Area: Associations with Vitamin D Intake and Skin Pigmentation. BMC Public Health, 8, 336. https://doi.org/10.1186/1471-2458-8-336</mixed-citation></ref><ref id="scirp.82630-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Abnet, C.C., Chen, W., Dawsey, S.M., et al. (2007) Serum 25(OH)-Vitamin D Concentration and Risk of Esophageal Squamous Dysplasia. Cancer Epidemiology, Biomarkers &amp; Prevention, 16, 1889-1893.  
https://doi.org/10.1158/1055-9965.EPI-07-0461</mixed-citation></ref><ref id="scirp.82630-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">Rajasree, S., Rajpal, K., Kartha, C.C., et al. (2001) Serum 25-Hydroxyvitamin D3 Levels Are Elevated in South Indian Patients with Ischemic Heart Disease. European Journal of Epidemiology, 17, 567-571.  
https://doi.org/10.1023/A:1014559600042</mixed-citation></ref><ref id="scirp.82630-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">Sinotte, M., Diorio, C., Bérubé, S., Pollak, M. and Brisson, J. (2009) Genetic Polymorphisms of the Vitamin D Binding Protein and Plasma Concentrations of 25-Hydroxyvitamin D in Premenopausal Women. The American Journal of Clinical Nutrition, 89, 634-640. https://doi.org/10.3945/ajcn.2008.26445</mixed-citation></ref><ref id="scirp.82630-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">Labuda, M., Labuda, D., Korab-Laskowska, M., et al. (1996) Linkage Disequilibrium Analysis in Young Populations: Pseudo-Vitamin D-Deficiency Rickets and the Founder Effect in French Canadians. American Journal of Human Genetics, 59, 633-643.</mixed-citation></ref><ref id="scirp.82630-ref42"><label>42</label><mixed-citation publication-type="other" xlink:type="simple">Hsu, J.J., Tintut, Y. and Demer, L.L. (2008) Vitamin D and Osteogenic Differentiation in the Artery Wall. Clinical Journal of the American Society of Nephrology, 3, 1542-1547. https://doi.org/10.2215/CJN.01220308</mixed-citation></ref><ref id="scirp.82630-ref43"><label>43</label><mixed-citation publication-type="other" xlink:type="simple">Tuohimaa, P. (2009) Vitamin D and Aging. The Journal of Steroid Biochemistry and Molecular Biology, 114, 78-84. https://doi.org/10.1016/j.jsbmb.2008.12.020</mixed-citation></ref><ref id="scirp.82630-ref44"><label>44</label><mixed-citation publication-type="other" xlink:type="simple">Harinarayan, C.V., et al. (2009) Vitamin D Status in India—Its Implications and Remedial Measures. A Review of over 50 Studies of 25(OH)D. Journal of the Association of Physicians of India, 57, 40-48. http://www.japi.org/jan_2009/R-1.html</mixed-citation></ref><ref id="scirp.82630-ref45"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Akhtar</surname><given-names> S. </given-names></name>,<etal>et al</etal>. (<year>2016</year>)<article-title>Prevalence and Correlates of Vitamin D Deficiency-Perspectives from Pakistan. MINI REVIEW. Department of Food Science and Technology, Bahauddin Zakariya University, Multan, Pakistan</article-title><source> Pakistan Journal of Pharmaceutical Sciences</source><volume> 29</volume>,<fpage> 1325</fpage>-<lpage>1330</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.82630-ref46"><label>46</label><mixed-citation publication-type="other" xlink:type="simple">Akhtar, S. (2016) Vitamin D Status of South Asian Populations—Risks and Opportunities. Critical Reviews in Food Science and Nutrition, 56, 1925-1940.  
https://doi.org/10.1080/10408398.2013.807419</mixed-citation></ref><ref id="scirp.82630-ref47"><label>47</label><mixed-citation publication-type="other" xlink:type="simple">Anjum, P., Safder, N., Khalid, M. and Mehboob, I. (2013) Vitamin D Deficiency in Pakistani Population. Journal of Pakistan Orthopaedic Association, 25, 18-19.</mixed-citation></ref><ref id="scirp.82630-ref48"><label>48</label><mixed-citation publication-type="other" xlink:type="simple">Mansoor, S., Habib, A., Ghani, F., et al. (2010) Prevalence and Significance of Vitamin D Deficiency and Insufficiency among Apparently Healthy Adults. Clinical Biochemistry, 43, 1431-1435. https://doi.org/10.1016/j.clinbiochem.2010.09.022</mixed-citation></ref><ref id="scirp.82630-ref49"><label>49</label><mixed-citation publication-type="other" xlink:type="simple">Sheikh, A., Saeed, Z., Jafri, S.A.D., et al. (2012) Vitamin D Levels in Asymptomatic Adults—A Population Survey in Karachi, Pakistan. PLoS ONE, 7, e33452.  
https://doi.org/10.1371/journal.pone.0033452</mixed-citation></ref><ref id="scirp.82630-ref50"><label>50</label><mixed-citation publication-type="other" xlink:type="simple">Bjelakovic, G., Gluud, L.L., Nikolova, D., et al. (2014) Vitamin D Supplementation for Prevention of Mortality in Adults. The Cochrane Database of Systematic Reviews (Systematic Review), 1, CD007470.  
https://doi.org/10.1002/14651858.CD007470.pub3</mixed-citation></ref><ref id="scirp.82630-ref51"><label>51</label><mixed-citation publication-type="other" xlink:type="simple">Bolland, M.J., Grey, A., Gamble, G.D. and Reid, I.R. (2014) The Effect of Vitamin D Supplementation on Skeletal, Vascular, or Cancer Outcomes: A Trial Sequential Meta-Analysis. The Lancet Diabetes &amp; Endocrinology (Meta-Analysis), 2, 307-320.  
https://doi.org/10.1016/S2213-8587(13)70212-2</mixed-citation></ref><ref id="scirp.82630-ref52"><label>52</label><mixed-citation publication-type="other" xlink:type="simple">Ross, A.C., Taylor, C.L., Yaktine, A.L. and Del Valle, H.B. (2011) Dietary Reference Intakes for Calcium and Vitamin D. National Academies Press, Washington, D.C.</mixed-citation></ref></ref-list></back></article>